We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Toshiba Awarded for Rapid Rise in CT Market

By MedImaging staff writers
Posted on 20 Feb 2007
Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, has selected Toshiba America Medical Systems (Tustin, CA, USA) as the recipient of the 2006 Frost & Sullivan Market Penetration Leadership Award in the North American computed tomography (CT) market. More...


Toshiba has quickly risen in the ranks to become a major medical imaging modality vendor and has penetrated key markets for imaging equipment including magnetic resonance imaging (MRI), CT, x-ray vascular, and ultrasound, experiencing double-digit growth rates across the board.

The company's penetration of the North American CT market is particularly impressive, since it has captured 19% of market revenues in 2005 in a highly competitive structure. Toshiba has developed an edge in the technology-driven North American market, indicating its ability to remain at the forefront of technologic and clinical advances. This is demonstrated by its remarkable performance in cardiology and oncology.

The company is successfully utilizing its expertise to develop sophisticated imaging systems using the latest technologies. Toshiba's work-in-progress is also significant, proving the company's mastery of advanced technology.

"Toshiba's next-generation CT scanner is a 256-slice system that features a 13-cm-wide detector that can capture any whole organ, including the heart and the brain, in a single rotation of the gantry, while offering superior whole-body scanning capabilities in trauma and stroke,” commented Frost & Sullivan research analyst Nadim Daher.

The system is expected to be commercially available in 2008 and is already attracting considerable interest at trade shows. This technologic advance will eliminate helical scanning and signify the advent of a whole-organ scanner that will provide an array of new clinical applications and further the clinical utility of CT.

Apart from delivering the highest standards of technology for the best value, Toshiba also works with best-in-class partners to provide a best-of-breed system. Powerful applications and workflow tools, an adequate information technology (IT) infrastructure, a future-proof archiving strategy, and the ability to provide access to CT imaging to end-users throughout the enterprise have become crucial to the successful utilization of CT equipment. Toshiba's strategic partnerships create a high level of aggregate industry expertise, which guarantees that its customers will benefit from the optimal systems.


Related Links:
Toshiba America Medical Systems
Frost & Sullivan

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.